The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268)

Drug Metabolism and Disposition

Volumn 26, Issue 1, 1998, Pages 73-77

  Coffman, Birgit L ^b   King, Christopher D ^b   Rios, Gladys R ^b   Tephly, Thomas R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTERONE; DIPRENORPHINE; GLUCURONOSYLTRANSFERASE; ISOENZYME; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; NALOXONE; NALTREXONE; OXAZEPAM; PROPRANOLOL; TESTOSTERONE;

ARTICLE; DRUG BLOOD LEVEL; DRUG GLUCURONIDATION; DRUG URINE LEVEL; ENZYME ACTIVITY; ENZYME MECHANISM; HUMAN; MOLECULAR CLONING; PRIORITY JOURNAL;

ANDROGENS; ANDROSTERONE; CELL LINE; GENE EXPRESSION; GLUCURONATES; GLUCURONOSYLTRANSFERASE; HUMANS; ISOENZYMES; KINETICS; MENTHOL; NARCOTICS; OXAZEPAM; PROPRANOLOL; RECOMBINANT PROTEINS; XENOBIOTICS;

EID: 0031894377     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Christrup LL (1997) Morphine metabolites. Acta Anasthesiol Scan 41:116-122.
2. Coffman BL, Green MD, King CD, and Tephly TR (1995) Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin. Mol Pharmacol 47:1101-1105.
3. Coffman BL, Rios GR, King CD, and Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Disp 25:1-4.
4. Green MD, Coffman BL, Irshaid YM, and Tephly TR (1988) Characterization of antibodies to a rabbit hepatic UDP-glucuronosyltransferase and the identification of an immunologically similar enzyme in human liver. Arch Biochem Biophys 262:367-374.
5. Green MD, Oturu EM, and Tephly TR (1994) Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 22:799-805.
6. Hashiguchi Y, Molina PE, and Abumrad NN (1995) Morphine-3-glucuronide hyperglycemic and neuroendocrine potentiating effects. Brain Res 694:13-20.
7. Jin C-J, Miners JO, Lillywhite KJ, and Mackenzie PI (1993) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 264:475-479.
8. Jin C-J, Mackenzie PI, and Miners JO (1997) The regio and stereoselectivity of C19 and C21 hydroxysteriod glucuronidation by UGT2B7 and UGT2B11. Arch Biochem Biophys 341:207-211.
9. King CD, Green MD, Rios GR, Coffman BL, Owens IS, Bishop WR, and Tephly TR (1996) The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys 332:92-100.
10. King CD, Rios GR, Green MD, Mackenzie PI, and Tephly TR (1997) Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. Drug Metab Disp 25:251-255.
11. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Roy Chowdhury J, Ritter JK, Schachter H, Tephly TR, Tipton KF, and Neben DW (1997) The UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
12. Matern H, Heinemann H, and Matern S (1994) Radioassay of UDP-glucuronosyltransferase activities toward endogenous substrates using labeled UDP-glucuronic acid and an organic solvent extraction procedure Anal Biochem 219:182-188.
13. Oguri K, Yamada-Mori I, Ishigezane I, Hirano T, and Yoshimura H (1987) Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugation at the 6-position. Life Sci 41:1457-1464.
14. Osborne R, Joel RS, Trew D, and Slevin M (1990) Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 47:12-19.
15. Patel M, Tang BK, Grant DM, and Kalow W (1995a) Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam. Pharmacogenetics 5:287-297.
16. Patel M, Tang BK, and Kalow W (1995b) (S) oxazepam is inhibited by ketoprofen and other substrates of UGT2B7. Pharmacogenetics 5:43-49.
17. Pasternak GW, Bodnar RJ, Clark JA, and Inturrisi CE (1987) Morphine-6-glucuronide, a potent mu agonist. Life Sci 41:2845-2849.
18. Puig JF, and Tephly TR (1986) Isolation and purification of rat liver morphine UDP-glucuronosyltransferase. Mol Pharmacol 30:558-565.
19. Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, and Owens IS (1992) A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isoenzymes with identical carboxyl termini. J Biol Chem 267:3257-3261.
20. Ritter JK, Sheen YY, and Owens IS (1989) Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. J Biol Chem 265:7900-7906.
21. Smith MT, Watt JA, and Cramond T (1990) Morphine-3-glucuronide: a potent antagonist of morphine analgesia. Life Sci 47:579-585.
22. Srinivasan V, Wielbo D, Simpkins J, Karlix J, Sloan K, and Tebbett I (1996) Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide. Pharm Res 13:296-300.
23. Vree TB, Baars AM, and Wuis EW (1991) Direct high pressure liquid chromatographic analysis and preliminary pharmacokinetics of enantiomers of oxazepam and temazepam with their corresponding glucuronide conjugates. Pharm Weekbl Sci 13:83-90.
24. Yue QY, Svensson JO, Alm C, Sjöqvist F, and Säwe J (1989) Interindividual and interethnic differences in the demethylation and glucuronidation of codeine. Br J Clin Pharmacol 28:629-637.